Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F W Sum

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Design|April 10, 1999
Recent developments in tetracycline antibioticsP E Sum, F W Sum, S J Projan
Journal of Medicinal Chemistry|April 20, 2001
(4-Piperidin-1-yl)phenyl amides: potent and selective human beta(3) agonistsB Hu, J Ellingboe, S Han, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2001
2,4-Thiazolidinediones as potent and selective human beta3 agonistsB Hu, J Ellingboe, I Gunawan, et al.
Cancer Research|September 1, 1986
Identification of human urinary mitoxantrone metabolitesF S Chiccarelli, J A Morrison, D B Cosulich, et al.
Bioorganic & Medicinal Chemistry|August 16, 2001
Novel (4-piperidin-1-yl)-phenyl sulfonamides as potent and selective human beta(3) agonistsB Hu, J Ellingboe, S Han, et al.
Journal of Medicinal Chemistry|July 3, 1998
5-Fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c]-[1, 4]benzodiazepin-10(11H)-ylcarbonyl)-3-chlorophenyl]benzamide (VPA-985): an orally active arginine vasopressin antagonist with selectivity for V2 receptorsJ D Albright, M F Reich, E G Delos Santos, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Prodrugs of CL316243: a selective beta3-adrenergic receptor agonist for treating obesity and diabetesF W Sum, A Gilbert, A M Venkatesan, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Design|April 10, 1999
Recent developments in tetracycline antibioticsP E Sum, F W Sum, S J Projan
Journal of Medicinal Chemistry|April 20, 2001
(4-Piperidin-1-yl)phenyl amides: potent and selective human beta(3) agonistsB Hu, J Ellingboe, S Han, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2001
2,4-Thiazolidinediones as potent and selective human beta3 agonistsB Hu, J Ellingboe, I Gunawan, et al.
Cancer Research|September 1, 1986
Identification of human urinary mitoxantrone metabolitesF S Chiccarelli, J A Morrison, D B Cosulich, et al.
Bioorganic & Medicinal Chemistry|August 16, 2001
Novel (4-piperidin-1-yl)-phenyl sulfonamides as potent and selective human beta(3) agonistsB Hu, J Ellingboe, S Han, et al.
Journal of Medicinal Chemistry|July 3, 1998
5-Fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c]-[1, 4]benzodiazepin-10(11H)-ylcarbonyl)-3-chlorophenyl]benzamide (VPA-985): an orally active arginine vasopressin antagonist with selectivity for V2 receptorsJ D Albright, M F Reich, E G Delos Santos, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Prodrugs of CL316243: a selective beta3-adrenergic receptor agonist for treating obesity and diabetesF W Sum, A Gilbert, A M Venkatesan, et al.
Pageof 1